JPH10120518A - Antimicrobial agent - Google Patents

Antimicrobial agent

Info

Publication number
JPH10120518A
JPH10120518A JP28098596A JP28098596A JPH10120518A JP H10120518 A JPH10120518 A JP H10120518A JP 28098596 A JP28098596 A JP 28098596A JP 28098596 A JP28098596 A JP 28098596A JP H10120518 A JPH10120518 A JP H10120518A
Authority
JP
Japan
Prior art keywords
silver
inorganic powder
antimicrobial agent
particles
antibacterial agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP28098596A
Other languages
Japanese (ja)
Other versions
JP3862244B2 (en
Inventor
Shinji Uchida
眞志 内田
Yasuo Kurihara
靖夫 栗原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SHINAON ZEOMITSUKU KK
Shinagawa Fuel Co Ltd
Original Assignee
SHINAON ZEOMITSUKU KK
Shinagawa Fuel Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHINAON ZEOMITSUKU KK, Shinagawa Fuel Co Ltd filed Critical SHINAON ZEOMITSUKU KK
Priority to JP28098596A priority Critical patent/JP3862244B2/en
Publication of JPH10120518A publication Critical patent/JPH10120518A/en
Application granted granted Critical
Publication of JP3862244B2 publication Critical patent/JP3862244B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

PROBLEM TO BE SOLVED: To obtain an antimicrobial agent high in stability, being hardly influenced by light, heat, pressure, chemical substances, etc., by using inorganic powder containing metal silver fine particles having particle diameters equal to or smaller than a fixed value. SOLUTION: This antimicrobial agent uses inorganic powder containing metal silver fine particles having <=10nm particle diameters. Preferably, the antimicrobial agent is prepared by using inorganic powder having an inclusion lattice. The inorganic powder having the inclusion lattice has properties of holding molecules in a part of a structure having a fine layered or a basket-like void and the extremely fine metal particles can be produced by taking advantage of the properties. Zeolite, layer phosphate, layer clay mineral, transition metal chalcogenide, graphite, etc., may be cited as the inorganic power having the inclusion lattice. The antimicrobial agent is used for drinking water treatment and providing a polymer molding material with antimicrobial properties.

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【発明の属する技術分野】本発明は、飲料水処理や高分
子成形材料に添加して抗菌性を付与する等に用いる抗菌
剤であって、光、熱、圧力、化学物質等による影響を受
けにくい安定性の高い抗菌剤に関する。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to an antibacterial agent used for drinking water treatment or for imparting antibacterial properties to a polymer molding material by adding it to an antibacterial agent, which is affected by light, heat, pressure, chemical substances and the like. It relates to a hardly stable antibacterial agent.

【0002】[0002]

【従来の技術】各種の高分子成形材料に抗菌剤を添加し
て抗菌性を有する成形品を得る試みが行われており、こ
のための抗菌剤も多く開発されている。このうち結晶性
アルミノケイ酸塩であるゼオライトに抗菌性金属イオン
である銀イオンを担持させた抗菌性ゼオライト(特開昭
60−181002号)やリン酸ジルコニウムに銀イオ
ンを担持させた抗菌剤(特開平3−83905号)が提
案されており、安全性や抗菌持続性の点で優れているこ
とが知られている。抗菌剤は、種々の加工を受ける際
に、また最終用途において、光、熱、圧力、化学物質等
による影響を受けることがあり、これらの影響を受けた
場合には、抗菌作用や外観上の着色、変色や機械的強度
などの物性が低下することがあった。特に、銀イオンを
含む抗菌剤はその抗菌性能は極めて高いが、光、熱、圧
力、化学物質に対して影響を受けやすいという欠点があ
った。
2. Description of the Related Art Attempts have been made to obtain an antibacterial molded article by adding an antibacterial agent to various polymer molding materials, and many antibacterial agents for this purpose have been developed. Among these, an antibacterial zeolite in which silver ions as antibacterial metal ions are supported on zeolite which is a crystalline aluminosilicate (JP-A-60-181002), and an antibacterial agent in which silver ions are supported on zirconium phosphate (see (Japanese Unexamined Patent Publication No. 3-83905) has been proposed and is known to be excellent in safety and antimicrobial durability. Antimicrobial agents may be affected by light, heat, pressure, chemicals, etc. when undergoing various processes and in the final use. Physical properties such as coloring, discoloration, and mechanical strength were sometimes reduced. In particular, antibacterial agents containing silver ions have extremely high antibacterial performance, but have a drawback that they are easily affected by light, heat, pressure and chemical substances.

【0003】[0003]

【発明が解決しようとする課題】従って、本発明の目的
は、種々の加工の際に、または最終用途において、光、
熱、圧力、化学物質等による、抗菌作用の低下、外観上
の着色、変色、機械的強度などの物性の低下のない、ま
たは少ない抗菌剤を提供することである。
Accordingly, it is an object of the present invention to provide light,
An object of the present invention is to provide an antibacterial agent which has no or little reduction in antibacterial action and physical properties such as coloring, discoloration and mechanical strength due to heat, pressure, chemical substances and the like.

【0004】[0004]

【課題を解決するための手段】本発明者等は上記課題を
解決するために種々検討した結果、粒子径が10nm以
下の金属銀微粒子が化学的に非常に安定であり、抗菌性
能も銀イオンを担持したものに匹敵することを見出し、
本発明を完成するに至った。本発明は、粒子径が10n
m以下の金属銀微粒子を含有する無機粉体であることを
特徴とする抗菌剤を提供するものである。銀粒子は物理
化学的に安定で、光、熱、圧力等の物理的影響を受けに
くく、また化学物質に対しても安定である。しかしなが
ら、銀粒子の一般的な粒子径である0.5μmでは、抗菌
作用がほとんどなく、実用的な抗菌剤としては不適当で
ある。
As a result of various studies conducted by the present inventors to solve the above-mentioned problems, it has been found that metallic silver fine particles having a particle diameter of 10 nm or less are chemically very stable, and that the antibacterial performance is high. Found to be comparable to those carrying
The present invention has been completed. The present invention has a particle diameter of 10 n.
The present invention provides an antibacterial agent characterized by being an inorganic powder containing metallic silver fine particles of m or less. Silver particles are physicochemically stable, are less susceptible to physical effects such as light, heat, and pressure, and are also stable to chemical substances. However, a silver particle having a general particle size of 0.5 μm has almost no antibacterial action and is not suitable as a practical antibacterial agent.

【0005】[0005]

【発明の実施の形態】以下本発明について詳細に説明す
る。金属銀粒子を微粉砕して10nmの均一な粒子を多
量に得ることは非常に困難である。このため、本発明に
使用される粒子径10nm以下の金属銀微粒子を含有す
る無機粉体を調製するには、包接格子を有する無機粉体
を用いることが望ましい。包接格子とは、原子や分子が
入り込む程度の隙間で、この包接格子を有する無機粉体
は微小な層状やかご状空洞を有する構造の部分に分子を
とじ込める性質を持っており、この性質を利用して均一
で非常に微細な金属銀粒子を製造することができる。本
発明において使用される、包接格子を有する無機粉体と
しては、ゼオライト、層状リン酸塩、層状粘度鉱物、遷
移金属カルコゲン化物、黒鉛、遷移金属酸化物、及び層
状酸素酸塩からなる群から選ばれた少なくとも1種を挙
げることができる
DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention will be described below in detail. It is very difficult to pulverize metallic silver particles to obtain a large amount of uniform particles of 10 nm. For this reason, in order to prepare an inorganic powder containing metal silver fine particles having a particle diameter of 10 nm or less used in the present invention, it is desirable to use an inorganic powder having an inclusion lattice. The inclusion lattice is a gap that allows atoms and molecules to enter, and the inorganic powder having this inclusion lattice has the property that molecules can be trapped in the part of the structure that has minute layered or cage-shaped cavities. Utilizing the properties, uniform and very fine metallic silver particles can be produced. As the inorganic powder having an inclusion lattice used in the present invention, zeolite, layered phosphate, layered viscosity mineral, transition metal chalcogenide, graphite, transition metal oxide, and layered oxyacid salt At least one selected

【0006】ゼオライトとしては、合成ゼオライトおよ
び天然ゼオライト、例えばA−型ゼオライト、X−型ゼ
オライト、Y−型ゼオライト、T−型ゼオライト、高シ
リカゼオライト、ソーダライト、モルデナイト、アナル
サイム、クリノプチロライト、チャバサイト、エリオナ
イト等を挙げることができる。層状リン酸塩としては、
リン酸ジルコニウム、リン酸チタン等を挙げることがで
きる。層状粘土鉱物としては、モンモリロナイト、バー
ミキュライト、カオリナイト、バイデライト、セピオラ
イト等を挙げることができる。遷移金属カルコゲン化物
としては、チタン、ジルコニウム、ハフニウム、モリブ
デン、タングステン、ニオブ、タンタル、バナジウム、
マンガン、ニッケル等の遷移金属と、イオウ、セレン、
テルル等のカルコゲン元素を含む化合物、例えば、Ta
2 、TaSe2 、NbS2 、VPS3 、MnPS3
NiPSe3 等を挙げることができる。
The zeolites include synthetic zeolites and natural zeolites, such as A-type zeolites, X-type zeolites, Y-type zeolites, T-type zeolites, high silica zeolites, sodalite, mordenite, analcyme, clinoptilolite, Chabasite, Erio Knight and the like can be mentioned. As the layered phosphate,
Zirconium phosphate, titanium phosphate and the like can be mentioned. Examples of the layered clay mineral include montmorillonite, vermiculite, kaolinite, beidellite, sepiolite and the like. Transition metal chalcogenides include titanium, zirconium, hafnium, molybdenum, tungsten, niobium, tantalum, vanadium,
Transition metals such as manganese and nickel, and sulfur, selenium,
Compound containing a chalcogen element such as tellurium, for example, Ta
S 2 , TaSe 2 , NbS 2 , VPS 3 , MnPS 3 ,
NiPSe 3 and the like.

【0007】遷移金属酸化物としては、酸化タングステ
ン、酸化レニウム、酸化ルテニウム、酸化バナジウム等
を挙げることができる。層状酸素酸塩としては、チタン
酸、ウラン酸、ニオブ酸、タングステン酸、モリブデン
酸、バナジン酸のアルカリ金属塩およびアルカリ土類金
属塩、例えば、チタン酸ナトリウム、ウラン酸ナトリウ
ム、ウラン酸カリウム、ニオブ酸カリウム、タングステ
ン酸ナトリウム、モリブデン酸マグネシウム、モリブデ
ン酸カルシウム、バナジン酸カリウム等を挙げることが
できる。その他銀粒子を担持する無機粉体としてはシリ
カゲル、アルミナゲル、活性炭、ガラス等を挙げること
ができる。
Examples of the transition metal oxide include tungsten oxide, rhenium oxide, ruthenium oxide, and vanadium oxide. Examples of the lamellar oxyacid salts include alkali metal salts and alkaline earth metal salts of titanic acid, uranic acid, niobic acid, tungstic acid, molybdic acid, and vanadic acid, for example, sodium titanate, sodium uranate, potassium uranate, and niobium. Potassium acid, sodium tungstate, magnesium molybdate, calcium molybdate, potassium vanadate and the like can be mentioned. Other examples of the inorganic powder supporting silver particles include silica gel, alumina gel, activated carbon, and glass.

【0008】本発明において無機粉体の粒子径は、種々
の加工において対応しやすい観点から0.1〜20μmの
粒度範囲に含まれるものが好ましい。また、無機粉体の
平均粒子径は0.3〜12μm、好ましくは0.5〜4
μmが適当である。本発明において無機粉体の比表面積
は、金属銀の微粒子を多く含有できるとの観点から80
2 /g以上であることが好ましく、その上限は特に限
定されないが、通常は900m2 /g以下である。
In the present invention, the particle diameter of the inorganic powder is preferably in the range of 0.1 to 20 μm from the viewpoint that it can be easily used in various processes. The average particle diameter of the inorganic powder is 0.3 to 12 μm, preferably 0.5 to 4 μm.
μm is appropriate. In the present invention, the specific surface area of the inorganic powder is 80 from the viewpoint that a large amount of metallic silver fine particles can be contained.
It is preferably at least m 2 / g, and the upper limit is not particularly limited, but is usually at most 900 m 2 / g.

【0009】本発明において無機粉体上に生成する粒子
径10nm以下の金属銀微粒子は、例えば、銀塩化合物
の溶液を無機粉体粒子に接触付着させて、これを還元さ
せることにより調製できる。本発明において抗菌剤調製
に使用する銀化合物としては、水溶性の銀化合物が好ま
しく、例えば、硝酸銀、硫酸銀、酢酸銀、塩素酸銀、過
塩素酸銀、ヘキサフルオロリン酸銀、テトラフルオロホ
ウ酸銀、ジアンミン銀硫酸塩等を挙げることができる。
無機粉体上に接触付着させた銀塩を還元する方法として
は、熱分解法と還元剤反応法がある。熱分解法は、銀化
合物の熱分解温度以上の温度で加熱する方法である。例
えば、硝酸銀の熱分解温度は444℃、酢酸銀の熱分解
温度は240℃、テトラフルオロホウ酸銀の熱分解温度
は200℃である。還元剤反応法は銀化合物に種々の還
元剤を作用させてこれを還元して金属銀にする方法であ
る。使用できる還元剤としては、糖類、アルデヒド類、
ハイドロキノン、ギ酸、シュウ酸、アスコルビン酸、亜
硝酸塩類、2価クロム塩類、2価鉄塩類、1価銅塩類、
4価ウラニウム塩類、2価バナジウム塩類、亜硫酸ガ
ス、亜硝酸ガス、一酸化炭素等を挙げることができる。
In the present invention, the fine metal silver particles having a particle diameter of 10 nm or less formed on the inorganic powder can be prepared, for example, by bringing a solution of a silver salt compound into contact with the inorganic powder particles and reducing the particles. As the silver compound used in the preparation of the antibacterial agent in the present invention, a water-soluble silver compound is preferable, for example, silver nitrate, silver sulfate, silver acetate, silver chlorate, silver perchlorate, silver hexafluorophosphate, tetrafluoroborane Silver acid, diammine silver sulfate and the like.
As a method for reducing the silver salt contacted and attached on the inorganic powder, there are a thermal decomposition method and a reducing agent reaction method. The thermal decomposition method is a method of heating at a temperature higher than the thermal decomposition temperature of the silver compound. For example, the thermal decomposition temperature of silver nitrate is 444 ° C, the thermal decomposition temperature of silver acetate is 240 ° C, and the thermal decomposition temperature of silver tetrafluoroborate is 200 ° C. The reducing agent reaction method is a method in which various reducing agents are allowed to act on a silver compound, and this is reduced to metallic silver. Reducing agents that can be used include sugars, aldehydes,
Hydroquinone, formic acid, oxalic acid, ascorbic acid, nitrites, divalent chromium salts, divalent iron salts, monovalent copper salts,
Examples thereof include tetravalent uranium salts, divalent vanadium salts, sulfurous acid gas, nitrous acid gas, and carbon monoxide.

【0010】本発明において抗菌剤中の銀粒子は10n
m以下のものが全銀粒子の60重量%以上、さらに好ま
しくは80重量%以上を占めていることが好ましい。な
おこの銀粒子の粒径は、点分解能0.5nm以下の電子顕
微鏡(明石製作所・EM−002A他)で測定できる。
また本発明において抗菌剤中の銀粒子の平均粒子径は、
1〜10nm、好ましくは4〜10nmが適当である。
本発明の無機粉体からなる抗菌剤は、銀粒子を抗菌剤重
量の0.7重量%以上、さらに好ましくは1.4重量%以上
含有することが抗菌性能の点から好ましい。本発明の抗
菌剤は、抗菌作用が要望される種々の分野で使用でき
る。例えば飲料水処理分野、食品包装分野、医療製品分
野、業務用家庭用調理製品分野、浴室関連分野、トイレ
関連分野等に使用できる。
In the present invention, the silver particles in the antibacterial agent are 10n.
m or less preferably account for 60% by weight or more, more preferably 80% by weight or more of the total silver particles. The particle size of the silver particles can be measured with an electron microscope (point: EM-002A, etc.) having a point resolution of 0.5 nm or less.
In the present invention, the average particle size of the silver particles in the antibacterial agent,
1 to 10 nm, preferably 4 to 10 nm is appropriate.
The antibacterial agent comprising the inorganic powder of the present invention preferably contains silver particles in an amount of 0.7% by weight or more, more preferably 1.4% by weight or more of the weight of the antibacterial agent from the viewpoint of antibacterial performance. The antibacterial agent of the present invention can be used in various fields where antibacterial action is required. For example, it can be used in the field of drinking water treatment, the field of food packaging, the field of medical products, the field of home cooking products for business use, the field of bathrooms, the field of toilets, and the like.

【0011】[0011]

【発明の効果】本発明の抗菌剤は、光、熱、圧力、化学
物質等による影響を受けにくく、安定性の高い抗菌作用
を長期間に渡って発揮できる。
The antibacterial agent of the present invention is hardly affected by light, heat, pressure, chemical substances and the like, and can exhibit a highly stable antibacterial action for a long period of time.

【0012】[0012]

【実施例】【Example】

実施例1〜5 無機粉体としてA−型ゼオライト粉体(Na2O・Al2O3
1.9 SiO2・xH2O:平均粒径1.5μm、比表面積720m2
/g)、リン酸ジルコニウム粉末(平均粒径0.6μm、
比表面積240m2/g)、セピオライト(平均粒径80
mesh、比表面積110m2/g)及びチタン酸ナトリウム
(平均粒径3.7μm、比表面積85m2/g)を、銀化合
物として酢酸銀を用い、熱分解法にて抗菌剤粉体を調製
した。調製は所定量の無機粉体と酢酸銀微粉体に少量の
水分を加えて混合した後、280〜300℃で1時間加
熱した。処方量と調製した抗菌剤粉体の銀含有量、その
他の測定値を表1に示す。
Examples 1 to 5 A-type zeolite powder (Na 2 O.Al 2 O 3.
1.9 SiO 2 .xH 2 O: average particle size 1.5 μm, specific surface area 720 m 2
/ G), zirconium phosphate powder (average particle size 0.6 μm,
Specific surface area 240 m 2 / g), sepiolite (average particle size 80
An antibacterial agent powder was prepared from a mesh, a specific surface area of 110 m 2 / g) and sodium titanate (average particle size of 3.7 μm, a specific surface area of 85 m 2 / g) by a thermal decomposition method using silver acetate as a silver compound. . For the preparation, a predetermined amount of inorganic powder and silver acetate fine powder were mixed with a small amount of water, and then heated at 280 to 300 ° C. for 1 hour. Table 1 shows the formulation amount, the silver content of the prepared antibacterial agent powder, and other measured values.

【0013】実施例6及び7 無機粉体としてY−型ゼオライト粉体(Na2O・Al2O3
2.4 SiO2・xH2O:平均粒径0.5μm、比表面積840m2
/g)、モンモリロナイト粉体(平均粒径100mesh、
比表面積280m2/g)を使用し、これを硝酸銀水溶液
に浸漬し表面に銀イオンを付着させた。これを水洗後、
10%アスコルビン酸水溶液を加えて、銀イオンを金属
塩に還元した。濾過し、100℃で乾燥して抗菌剤を調
製した。調製した抗菌剤粉体の銀含有量、その他の測定
値を表2に示す。
Examples 6 and 7 Y-type zeolite powder (Na 2 O.Al 2 O 3.
2.4 SiO 2 xH 2 O: average particle size 0.5 μm, specific surface area 840 m 2
/ G), montmorillonite powder (average particle size 100mesh,
A specific surface area of 280 m 2 / g) was immersed in an aqueous solution of silver nitrate to deposit silver ions on the surface. After washing this with water,
A 10% aqueous solution of ascorbic acid was added to reduce silver ions to metal salts. After filtration and drying at 100 ° C., an antibacterial agent was prepared. Table 2 shows the silver content of the prepared antibacterial agent powder and other measured values.

【0014】比較例1〜3 比較例として、銀粒子を含まないリン酸ジルコニウム粉
末(平均粒径0.6μm、比較例1)、銀イオン置換リン
酸ジルコニウム粉末(銀イオン含有量:3.1%、平均粒
径0.6μm、比較例2)、及び平均粒径が10μmの銀
粒子(比較例3)を用意した。
Comparative Examples 1 to 3 As comparative examples, zirconium phosphate powder containing no silver particles (average particle size: 0.6 μm, Comparative Example 1), silver ion-substituted zirconium phosphate powder (silver ion content: 3.1) %, An average particle diameter of 0.6 μm, Comparative Example 2), and silver particles having an average particle diameter of 10 μm (Comparative Example 3).

【0015】試験例1(抗菌力試験) 実施例、比較例で得た粒子の抗菌力を、日本化学療法学
会標準法による最小発育阻止濃度(MIC)、最小死滅
濃度(MBC)を、黄色ブドウ球菌と緑膿菌のそれぞれ
の菌種について測定することにより評価した。結果を表
3に示す。 試験例2(光、熱、化学物質に対する耐久性試験) 実施例、比較例で得た粒子について種々の耐久性を評価
するため、下記の処理を行った後、日本化学療法学会標
準法による最小発育阻止濃度(MIC)、最小死滅濃度
(MBC)を黄色ブドウ球菌について測定した。結果を
表4、表5に示す。 処理A:紫外線ランプ(20W)2本を距離10cmにて
1000時間照射した。 処理B:窒素雰囲気中で800℃で96時間加熱した。 処理C:1規定濃度水酸化ナトリウム水溶液に20℃で
96時間浸漬後、水洗した。 処理D:1規定濃度次亜塩素酸ナトリウム水溶液に20
℃で96時間浸漬後、水洗した。
Test Example 1 (Antibacterial activity test) The antibacterial activity of the particles obtained in Examples and Comparative Examples was determined by measuring the minimum inhibitory concentration (MIC) and the minimum killing concentration (MBC) according to the standard method of the Japanese Society of Chemotherapy. The evaluation was performed by measuring each of the bacterial species of Streptococcus and Pseudomonas aeruginosa. Table 3 shows the results. Test Example 2 (Durability Test for Light, Heat, and Chemical Substances) In order to evaluate the various durability of the particles obtained in the examples and comparative examples, the following treatments were performed, and then the minimum value was determined according to the standard method of the Japanese Society of Chemotherapy. The growth inhibitory concentration (MIC) and the minimum kill concentration (MBC) were measured for S. aureus. The results are shown in Tables 4 and 5. Treatment A: Two UV lamps (20 W) at a distance of 10 cm
Irradiated for 1000 hours. Treatment B: heated at 800 ° C. for 96 hours in a nitrogen atmosphere. Treatment C: The substrate was immersed in a 1N aqueous solution of sodium hydroxide at 20 ° C. for 96 hours and then washed with water. Treatment D: 20% aqueous solution of sodium hypochlorite at 1N concentration
After immersion at 96 ° C for 96 hours, it was washed with water.

【0016】[0016]

【表1】 表1 ─────────────────────────────────── 実施例 無機粉体 金属銀微粒子含有抗菌剤 種 類 銀含有量 銀粒子平 10nm以下の銀粒子 (%) 均径(nm) の含有量(重量% 1 A−型ゼオライト 2.5 8.0 70 2 A−型ゼオライト 0.7 5.5 90 3 リン酸ジルコニウム 2.8 5.8 70 4 セピオライト 1.2 7.0 80 5 チタン酸ナトリウム 5.8 9.5 60 [Table 1] Table 1 Example Inorganic powder containing metallic silver fine particles Antibacterial agent type Silver content Silver particles having a silver particle diameter of 10 nm or less (%) Content of uniform diameter (nm) (% by weight) 1 A-type zeolite 2.5 8.0 70 2 A-type zeolite 0.75 5.5 90 3 Zirconium phosphate 2.8 5.8 704 Sepiolite 1.2 7.0 805 Sodium titanate 5.8 9.5 60

【0017】[0017]

【表2】 表2 ─────────────────────────────────── 実施例 無機粉体 金属銀微粒子含有抗菌剤 種 類 銀含有量 銀粒子平 10nm以下の銀粒子 (%) 均径(nm) の含有量(重量% 6 Y−型ゼオライト 1.4 9.0 70 7 モンモリロナイト 2.6 9.0 70 [Table 2] Example 2 Inorganic powder containing metallic silver fine particles Antibacterial agent Type Silver content Silver particles having a particle size of 10 nm or less (%) Content of uniform diameter (nm) (% by weight 6 Y-type zeolite 1.4 9.0 707 Montmorillonite 2.6 9.0 70

【0018】[0018]

【表3】 表3 単位:ppm ─────────────────────────────────── 試料 黄色ブドウ球菌 緑 膿 菌 MIC MBC MIC MBC 実施例1 250 500 250 500 実施例2 62 500 62 250 実施例3 62 500 125 500 実施例4 250 1000 250 500 実施例5 250 250 125 500 実施例6 62 250 250 500 実施例7 62 250 125 250 比較例1 2000以上 2000以上 2000以上 2000以上 比較例2 250 1000 500 2000比較例3 2000以上 2000以上 2000以上 2000以上 Table 3 Unit: ppm ─────────────────────────────────── Sample Staphylococcus aureus Green pus Bacteria MIC MBC MIC MBC Example 1 250 500 250 500 Example 2 62 500 62 250 Example 3 62 500 125 500 Example 4 250 1000 250 250 Example 5 250 250 125 125 500 Example 6 62 250 250 500 Example 7 62 250 125 250 Comparative Example 1 2000 or more 2000 or more 2000 or more 2000 or more Comparative Example 2 250 1000 500 2000 Comparative Example 3 2000 or more 2000 or more 2000 or more 2000 or more

【0019】[0019]

【表4】 表4 ─────────────────────────────────── 試料 黄色ブドウ球菌のMIC、MBC(ppm) 処理A 処理B 処理C 処理D MIC MBC MIC MBC MIC MBC MIC MBC 実施例1 250 500 250 500 250 500 250 500 実施例2 62 250 62 500 62 250 62 500 実施例3 62 250 62 500 62 500 62 500 実施例4 250 1000 250 1000 250 500 250 500 実施例5 62 250 62 250 62 250 62 250 実施例6 62 250 62 250 62 250 62 250 実施例7 62 250 62 250 62 250 62 250 比較例1 2,000以上 - 2,000以上 - 2,000以上 - 2,000以上 - 比較例2 2,000以上 - 2,000以上 - 2,000以上 - 2,000以上 -比較例3 2,000以上 - 2,000以上 - 2,000以上 - 2,000以上 - ※2000以上はMICの値である。Table 4 ─────────────────────────────────── MIC, MBC ( ppm) Treatment A Treatment B Treatment C Treatment D MIC MBC MIC MBC MIC MBC MIC MBC Example 1 250 500 250 500 250 500 250 500 Example 2 62 250 62 500 62 250 62 500 Example 3 62 250 62 500 62 500 62 500 Example 4 250 1000 250 1000 250 500 250 500 Example 5 62 250 62 250 62 250 62 250 Example 6 62 250 62 250 62 250 62 250 Example 7 62 250 62 250 62 250 62 250 Comparative example 1 2,000 or more -2,000 or more-2,000 or more-2,000 or more-Comparative Example 2 2,000 or more-2,000 or more-2,000 or more-2,000 or more- Comparative Example 3 2,000 or more-2,000 or more-2,000 or more-2,000 or more-* 2,000 or more are MIC values.

【0020】[0020]

【表5】 表5 ─────────────────────────────────── 試料 抗菌剤の色の変化 処理A 処理B 処理C 処理D 実施例1 白 色 白 色 白 色 白 色 実施例2 白 色 白 色 白 色 白 色 実施例3 白 色 白 色 白 色 白 色 実施例4 白 色 白 色 白 色 白 色 実施例5 白 色 白 色 白 色 白 色 実施例6 白 色 白 色 白 色 白 色 実施例7 白 色 白 色 白 色 白 色 比較例1 白 色 白 色 白 色 白 色 比較例2 黄白色 灰 色 灰白色 黄褐色比較例3 灰白色 灰白色 灰白色 灰白色 [Table 5] 処理Color change treatment A of sample antibacterial agent Process B Process C Process D Example 1 White White White White White Example 2 White White White White White Example 3 White White White White White Example 4 White White White White White Example 5 White White White White White Example 6 White White White White White Example 7 White White White White White Comparative Example 1 White White White White White Comparative Example 2 Yellow White Gray Color Gray-white Yellow-brown Comparative Example 3 Gray-white Gray-white Gray-white Gray-white

Claims (2)

【特許請求の範囲】[Claims] 【請求項1】 粒子径が10nm以下の金属銀微粒子を
含有する無機粉体であることを特徴とする抗菌剤。
1. An antibacterial agent which is an inorganic powder containing metal silver fine particles having a particle size of 10 nm or less.
【請求項2】 無機粉体が、包接格子を有する、ゼオラ
イト、層状リン酸塩、層状粘度鉱物、遷移金属カルコゲ
ン化物、黒鉛、遷移金属酸化物、及び層状酸素酸塩から
なる群から選ばれた少なくとも1種である請求項1記載
の抗菌剤。
2. The inorganic powder is selected from the group consisting of zeolite, layered phosphate, layered clay mineral, transition metal chalcogenide, graphite, transition metal oxide, and layered oxyacid having an inclusion lattice. The antibacterial agent according to claim 1, which is at least one kind.
JP28098596A 1996-10-23 1996-10-23 Antibacterial agent Expired - Fee Related JP3862244B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP28098596A JP3862244B2 (en) 1996-10-23 1996-10-23 Antibacterial agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP28098596A JP3862244B2 (en) 1996-10-23 1996-10-23 Antibacterial agent

Publications (2)

Publication Number Publication Date
JPH10120518A true JPH10120518A (en) 1998-05-12
JP3862244B2 JP3862244B2 (en) 2006-12-27

Family

ID=17632656

Family Applications (1)

Application Number Title Priority Date Filing Date
JP28098596A Expired - Fee Related JP3862244B2 (en) 1996-10-23 1996-10-23 Antibacterial agent

Country Status (1)

Country Link
JP (1) JP3862244B2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020516582A (en) * 2017-04-10 2020-06-11 カモン、ルイス ヘスス ロスタオ Nanosystems containing silver and antibiotics and uses for the treatment of bacterial infections
KR20210022829A (en) * 2019-08-21 2021-03-04 주식회사 씨피알에스앤티 Packaging container with antimicrobial and antifungal activity and method for manufacturing the same

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2020516582A (en) * 2017-04-10 2020-06-11 カモン、ルイス ヘスス ロスタオ Nanosystems containing silver and antibiotics and uses for the treatment of bacterial infections
US11304974B2 (en) 2017-04-10 2022-04-19 Laboratorios Enosan, S.L. Nanosystems comprising silver and antibiotics and their use for the treatment of bacterial infections
KR20210022829A (en) * 2019-08-21 2021-03-04 주식회사 씨피알에스앤티 Packaging container with antimicrobial and antifungal activity and method for manufacturing the same

Also Published As

Publication number Publication date
JP3862244B2 (en) 2006-12-27

Similar Documents

Publication Publication Date Title
CA2167030C (en) An antimicrobial polymer composition
JPH0640829A (en) Production of antimicrobial agent
JP5669367B2 (en) Antibacterial deodorant and method for producing the same
JP5354852B2 (en) Deodorant antibacterial composition
Singh et al. Antibacterial and photocatalytic active transparent TiO2 crystallized CaO–BaO–B2O3–Al2O3–TiO2–ZnO glass nanocomposites
JPS60100504A (en) Antibacterial composition and its production
JPS6270221A (en) Amorphous aluminosilicate having antimicrobial and/or germicidal action
EP3184492B1 (en) Antiseptic formulation
JPH10120518A (en) Antimicrobial agent
JP4355835B2 (en) Photocatalytic material
JPS63246167A (en) White deodorant and its production
JP5854590B2 (en) Antibacterial / deodorant treatment agent and antibacterial / deodorant treatment article
JPS60202162A (en) Antiseptic and mildewproofing paint composition
JPH06239713A (en) Antimicrobial zeolite and its production
JPS63250309A (en) Antibacterial agent
JPH06263916A (en) Antimicrobial agent and antimicrobial resin composition
JPH0390007A (en) Antimicrobial agent
JPS61136530A (en) Treatment of polymer molding containing zeolite particle
JP2567719B2 (en) Antibacterial zeolite
JPH05148116A (en) Antibacterial mildew-proofing composition and its production
JPH02111709A (en) Powdery antibacterial and antimycotic agent and production thereof
JP2006089380A (en) Method for producing antibacterial and deodorizing colloidal solution of titanium oxide
JP2001233719A (en) Bactericidal material and bactericidal method
KR20010044617A (en) Manufacturing method of sterilization drug and packing paper of food therefor
JPH09157119A (en) Antibacterial agent

Legal Events

Date Code Title Description
A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20060417

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20060424

A521 Written amendment

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20060623

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20060911

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20060925

R150 Certificate of patent or registration of utility model

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20101006

Year of fee payment: 4

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20111006

Year of fee payment: 5

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20121006

Year of fee payment: 6

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20131006

Year of fee payment: 7

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees